Page 1

APR. 2010

APRIL 22, 2010

Every day, pharmacies depend on PPSC to simplify purchasing, reduce costs and identify new revenue sources – making a significant impact on their bottom line.

Increase Profits

PPSC can help you: EXPAND use of high-profit generics CREATE effective store layout ENHANCE third-party profits CAPTuRE MTM revenue EsTAblisH new business niches INCREASE your overall margins

Independent…But Not Alone. PPSC is Your Partner for Success For more on how PPSC can maximize the potential of your independent pharmacy, visit or call toll-free 888-778-9909.

To all of my friends and colleagues in the pharmacy profession, No words printed or spoken can express the gratitude, appreciation and love that the Jackson family has for the pharmacy community. In February we quietly laid my father to rest in peace having been among us for 90 wonderful years. Dad was not only a father, teacher and mentor but he was also my friend. I have learned that it is not easy to say goodbye to those who have such significant influence and are masterful at guiding people though life’s many adventures. The profession has many challenges before it and as such the Jacksons elected to not burden the membership with any public announcements of my father’s passing. Still having said that, we have been overwhelmed with the outpouring of support and comfort from both members and non-members of the Florida Pharmacy Association. While it is my wish and desire to personally respond and give sincere thanks to the vast number of messages, calls, letters, e-mails and cards, I have found it quite difficult to do at this time due to our efforts to concentrate on our advocacy programs. I hope that you receive this message as our humble and modest way of saying thank you with all sincerity and that peace be with you. With kindest regards,

Michael Jackson & Family Executive Vice President and CEO, Florida Pharmacy Association

2 |

Florida Pharmacy TodaY

florida PHARMACY TODAY Departments 4 Calendar 4 Advertisers

VOL. 73 | NO. 4 APRIL 2010 the official publication of the florida pharmacy association



Earth Day


120th Annual Convention and Meeting


Government Affairs Issue Brief

5 President’s Viewpoint 7 Executive Insight 18 Poster Abstracts 38 Buyer’s Guide

Marco Island Marriott Resort, Golf Club & Spa Marco Island, FL June 30 - July 4, 2010

Drug Enforcement Administration Releases Interim Final Rule to Permit Electronic Prescriptions for Controlled Substances

A P RIL 2 0 1 0



FPA Calendar 2010

APRIL 16-18 FPA Clinical Consultant Conference Tampa Airport Marriott 30

Legislative session ends MAY


NASPA Leadership Conference Austin, Texas

10 - 12 2010NCPA Legislative Conference Washington, DC 19

Advisory Council on Pharmacy Practice - Florida Pharmacy Council post session conference

30 - 4 FPA Annual Meeting and Convention, Marco Island Marriott JULY 5

10 - 14 AACP Annual Meeting Seattle, Washington 30



26 - 28 ASCP Midyear Clinical Conference Phoenix, Arizona 31

Memorial Day, FPA Office Closed JUNE


FPA Leadership Retreat


Florida Board of Pharmacy Meeting Tampa, Florida

FPA Office Closed

FPA Legislative Committee Meeting Orlando, Florida FSHP Annual meeting Southeast Officer's Conference New Orleans, LA AUGUST


27th Annual Southeastern Gatherin Hilton Sandestin Beach

10-11 Board of Pharmacy Meeting Crowne Plaza, Orlando

For a complete calendar of events go to CE CREDITS (CE cycle) The Florida Board of Pharmacy requires 10 hours LIVE Continuing Education as part of the required 30 hours general education needed every license renewal period. Pharmacists should have satisfied all continuing education requirements for this biennial period by September 30, 2011 or prior to licensure renewal. *For Pharmacy Technician Certification Board Application, Exam Information and Study materials, please contact Ranada Simmons in the FPA office. For More Information on CE Programs or Events: Contact the Florida Pharmacy Association at (850) 222-2400 or visit our Web site at www. CONTACTS FPA — Michael Jackson (850) 222-2400 FSHP — Michael McQuone (850) 906-9333 U/F — Dan Robinson (352) 273-6240 FAMU — Leola Cleveland (850) 599-3301 NSU — Carsten Evans (954) 262-1300 DISCLAIMER Articles in this publication are designed to provide accurate and authoritative information with respect to the subject matter covered. This information is provided with the understanding that neither Florida Pharmacy Today nor the Florida Pharmacy Association are engaged in rendering legal or other professional services through this publication. If expert assistance or legal advice is required, the services of a competent professional should be sought. The use of all medications or other pharmaceutical products should be used according to the recommendations of the manufacturers. Information provided by the maker of the product should always be consulted before use.

4 |

Florida Pharmacy TodaY

Mission Statements: of the Florida Pharmacy Today Journal

The Florida Pharmacy Today Journal is a

peer reviewed journal which serves as a medium through which the Florida Pharmacy Association

can communicate with the profession on advances in the sciences of pharmacy, socio-economic is-

sues bearing on pharmacy and newsworthy items

of interest to the profession. As a self-supported journal, it solicits and accepts advertising congruent with its expressed mission.

of the Florida Pharmacy Today Board of Directors

The mission of the Florida Pharmacy Today

Board of Directors is to serve in an advisory capacity to the managing editor and executive editor of

the Florida Pharmacy Today Journal in the establishment and interpretation of the Journal’s

policies and the management of the Journal’s

fiscal responsibilities. The Board of Directors also serves to motivate the Florida Pharmacy Associa-

tion members to secure appropriate advertising to assist the Journal in its goal of self-support.

Advertisers Healthcare consultants........................ 3 Kahan ◆ SHIR, P.L.......................................... 13

MEDICAL STAFFING.......................................... 8 PHARMACY PROVIDER SERVICES (PPSC)......................................... 11 philadelphia college................................ 2 Rx RElief.......................................................... 12

E-mail your suggestions/ideas to

The President’s Viewpoint KAREN WHALEN, FPA President

The Voyage to Professionalism Following is a transcript of remarks that I delivered to first-year pharmacy students at the University of Florida College of Pharmacy White Coat Ceremony. Although these remarks on professionalism were geared towards pharmacy students, the six tenets of professionalism are core values and attitudes expected of any member of our profession of pharmacy. So, read on to see how you far you’ve traveled on your voyage to professionalism… Thank you for the kind introduction. I am genuinely grateful for the opportunity to share in this special day with you. Let me start by offering you my sincere congratulations on reaching this important point in your pharmacy school career. So, in a few minutes you will all receive your white coats. What is the meaning of the white coat? The white coat is much more than just a clean, crisp article of clothing. It is an outward symbol of professionalism. However, professionalism cannot be obtained simply by donning your white coat during the ceremony today. Nor can professionalism be acquired by reading a textbook, watching a lecture, or reviewing your notes. Instead, the attainment of professionalism is a journey, an expedition that may take several years as you begin to make a lifelong commitment to behaviors, values, and attitudes consistent with and expected of members of our profession of pharmacy. Today, I would like to speak to you about the meaning of the white coat and provide you with some pointers on your personal voyage to professionalism. Already you are almost one year into your fantastic voyage. Hopefully, it has been smooth sailing so far! As you continue your educational journey

with the College of Pharmacy over the next three years, how will you know that you are making adequate progress towards your desired destination of professionalism? Seasoned travelers will tell you that the key to planning a successful journey is the use of an appropriate and up-to-date travel guide. Luckily, there is a travel guide designed expressly for you – written by pharmacy students for pharmacy students. The title of this guidebook is “Tenets of Professionalism for Pharmacy Students”, but for the purposes of our discussion today, we will refer to it as “Travel Tips for Pharmacy Students on the Road to Professionalism.” Since this travel guide is designed by students for students, it is short (six travel tips with everything you need to know in three pages or less), it costs nothing (easily downloadable from the internet to your phone or handheld device), and it even comes with its own simple to memorize mnemonic (PHARM.D.) Professional Presence When planning a trip, one of the first things on every traveler’s mind is what to pack. The first of the six travel tips and the “P” of the PHARM.D. mnemonic is Professional Presence. In other words, pack your white coat!! By maintaining a professional presence on your journey, you will be able to instill trust and confidence in your patients, peers, and other health care professionals. Demonstrating a professional presence means maintaining professional dress, behaviors, and attitudes in any arena where you are representing the profession of pharmacy. This includes the classroom setting, the experiential environment, and attendance at professional pharmacy meetings. The guidebook also recommends that the concept of professional presence should extend

Karen Whalen, 2009-2010 FPA President

into your personal life. Undoubtedly, this is one of the hardest parts on the road to becoming a healthcare professional. There are no “off and on” times when professional behavior is expected or not. It must be a part of your lives, day in and day out. So, remember, whether you are traveling for business or for pleasure, professional presence is a must! Honesty The second thing most travelers want to know is “What is the best way to get to my final destination?” According to this travel guide, following the road marked “honesty and integrity” is the only recommended route. Thus, the “H” of the Pharm.D. mnemonic stands for honesty and integrity. During your journey through pharmacy school, you will be presented with many opportunities to veer off the path of honesty and integrity. As you come to these forks in the road, alternate routes may challenge your moral integrity by enticing you with short A P RIL 2 0 1 0



cuts, quick fixes, and two-for-one travel deals that sound too good to be true. Do not be fooled. Stick with your original itinerary. These other paths frequently deprive you of needed travel experiences and are often filled with speed traps, pot holes, and sometimes even dead end roads. Altruism Another common question asked by travelers is “How do I create the most memorable experiences during my trip?” For this, the guidebook advocates the use of altruism. Altruism, or unselfish concern for the welfare of others, is the “A” of the Pharm.D. mnemonic. Without a doubt, the book recommends, “for maximizing memorable moments on your journey, you need only to ‘make a commitment to serve the best interests of the patient above your own.’ ” After all, when your journey is over, you probably won’t remember if you made it from one destination to another in time to watch reruns of your favorite show, or if you checked off all the items on your “to-do” list on each day of your trip. You may not even remember how many days you spent at each stop along the way, or the sites that you saw in each place. What you will remember are the times when you made a significant difference in a patient’s life – and they, in turn, will remember you. Respect for Others Most travelers also want to know how to prevent travel mishaps along the way. The answer is simple – use respect for others. Respect for others represents the “R’ in the Pharm.D. mnemonic. When you remember this travel tip, think of the golden rule – “treat others as you would want to be treated.” During your voyage, it is essential to treat your tour guides with respect – these include your faculty members, pharmacist preceptors, and other healthcare providers. Your tour guides are very familiar with this terrain. If you listen attentively and solicit their feedback, you will gain more valuable advice and learn more life lessons than you can possibly imagine. Most importantly, it is imperative to 6 |

Florida Pharmacy TodaY

show respect for the patients you meet along the way. There will be days when patients may offend you with their harsh words, and their indifference to life-saving therapies, but it is important to always come from a place of compassion, empathy, and kindness. Keep in mind that you do not how far your patients may have traveled or the difficulties that they may have faced on their own personal journeys. Maintenance of Professional Stewardship As you continue on your journey, it is critical to future pharmacy travelers that you keep the paths open and well maintained. This is known as maintenance of professional stewardship. Stewardship has become somewhat of a buzzword in the pharmacy world these days. In case you are not familiar with the term, Merriam-Webster defines stewardship as “the careful and responsible management of something entrusted to one’s care.” In this case, professional stewardship refers to maintenance and care of your profession of pharmacy. You can help maintain and uphold the profession by actively participating in pharmacy organizations and other worthwhile endeavors in the profession of pharmacy. Who knows, you may even blaze some bigger and better trails for your successors to follow. After all, it is YOUR profession. If you won’t look after it, maintain it, and seek to advance it, then who will? Dedication and Commitment to Excellence The last key to a successful voyage is the “D” of Pharm.D. mnemonic - Dedication and Commitment to Excellence. This travel tip reminds you that you alone are ultimately accountable for achieving a successful outcome on your educational journey. In other words, you must assume full responsibility for own your learning and professional development. As students in the College of Pharmacy, you must all master core concepts and skills necessary to practice pharmacy in order to reach that magical destination where you walk across the stage and receive

your diploma. There is no easy way to do this, and there is certainly no substitute for learning the information – patients’ lives will depend on your mastery of the material. Late nights spent memorizing med chem structures, preparing for pharmacotherapy verbal defense, and studying for pharmacology exams are all tolls that you must pay to continue your expedition to excellence. The good news is that this trip does not end when you finish pharmacy school. With emerging technologies and a continually expanding array of new drug developments, it is crucial that you continue on a mission of lifelong learning after graduation. So, in closing, the white coat brings with it great opportunities, but it also means great responsibilities. As you don your white coat today and officially embark on the next phase of your voyage, I challenge each of you to pick up a copy of the latest “travel guide” and endeavor to present a professional presence, exhibit honesty and integrity, practice altruism, demonstrate respect for others, maintain professional stewardship, and dedicate yourself to excellence. I think I speak for the entire faculty of the College of Pharmacy when I tell you how very proud of you we all are. I wish you good luck and God speed on each of your personal journeys. n Reference:

American College of Clinical Pharmacy. Tenets of Professionalism for Pharmacy Students. Pharmacotherapy 2009;29(6):757–759.

Executive Insight By Michael Jackson, FPA Executive by michael jackson,Vice RPhPresident/CEO


Florida Legislature Crafting Health Care Policy for 2010

he making of sausage is not a pretty site, however, for some, when the work is done the taste preference is whether or not the correct spices, herbs and ingredients are favorable to the consumer. The making of laws and public policy are not much different. For eight to nine weeks, the Florida Legislature has been gathering to discuss various issues that are of interest to the profession and business of pharmacy. This year, the somber theme in the halls of government are the budgetary challenges that Florida is facing in its efforts to cover the costs related to essential services given the available pool of dollars. Not much else gets done when these debates rage on spending priorities. As this magazine gets posted online, I have included in this article a listing of the major issues that the Florida Pharmacy Association is monitoring or working on your behalf. None of these issues, as of the date of publication, have been passed by the Legislature and signed by the Governor. Many will likely never get to the finish line. Some of the proposals may end up entirely different from the description in this article. To get a full report on the outcome of this two-month dash during this lawmaking track meet, plan to visit with us at the annual convention this summer at Marco Island, Florida. HB 7223 and HB 7225 Relating to Medicaid Managed Care Creates pt. IV, CH. 409, F.S., entitled Medicaid Managed Care; designates AHCA as single state agency to administer Medicaid program; establishes Medicaid program as statewide,

integrated managed care program for all covered services; authorizes agency to apply for and implement waivers; provides related and conforming provisions to reorganization of Medicaid managed care. Provides for expiration of various provisions of law on specified dates to conform to reorganization of Medicaid managed care; revises provisions relating to home and community-based services delivery system for persons with developmental disabilities; authorizes AHCA to enroll entities as Medicare crossover-only providers for payment purposes only, etc. SUMMARY: Moves 2.7 million patients into the managed care market resulting in restricted pharmacy networks. HB 5001 Appropriations Conference Report Changes the ingredient cost formula for Florida Medicaid. Revisions include removing Average Wholesale Price AWP from the lower of ingredient cost calculation and also revising the Wholesale Acquisition Cost (WAC) from WAC + 4.75% to even WAC. This likely will place pharmacy reimbursement at or near post First Databank settlement calculations that began in September of 2009. Essentially, this is a continued reduction on pharmacy reimbursement. HB 0037 Relating to Health Care Services - Representative Plakon Health Care Services: Proposes creation of s. 28, Art. I of State Constitution to prohibit laws or rules from compelling any person, employer, or health care provider to participate in any health care system, permit person

Michael Jackson, B.Pharm

or employer to purchase lawful health care services directly from health care provider, permit health care provider to accept direct payment from person or employer for lawful health care services, exempt persons, employers, and health care providers from penalties and fines for paying or accepting direct payment for lawful health care services, and permit purchase or sale of health insurance in private health care systems; specifies what amendment does not affect or prohibit. HB 0045 Relating to Use of Prescribed Pancreatic Enzyme Supplements - Representative Renuart Use of Prescribed Pancreatic Enzyme Supplements: Authorizes certain K-12 students to use prescribed pancreatic enzyme supplements under certain circumstances; requires State Board of Education to adopt rules; provides for indemnification.

A P RIL 2 0 1 0



FPA Staff Executive Vice President/CEO Michael Jackson (850) 222-2400, ext. 200

Director of Continuing Education Tian Merren-Owens, ext. 120 Controller Wanda Hall , ext. 211

Membership Coordinator Ranada Simmons , ext. 110

Educational Services Office Assistant Stacey Brooks , ext. 210 Florida Pharmacy Today Board Chair Designate........Betty Harris, Lighthouse Point Treasurer...............................Stephen Grabowski, Tampa Secretary.........................Stuart Ulrich, Boynton Beach Member................. Don Bergemann, Member..................................... Joseph Koptowsky, Miami Member...................................... Jennifer Pytlarz, Brandon Executive Editor.........Michael Jackson, Tallahassee Managing Editor.........................Dave Fiore, Tallahassee

This is a peer reviewed publication. ©2010, FLORIDA PHARMACY JOURNAL, INC. ARTICLE ACCEPTANCE: The Florida Pharmacy Today is a publication that welcomes articles that have a direct pertinence to the current practice of pharmacy. All articles are subject to review by the Publication Review Committee, editors and other outside referees. Submitted articles are received with the understanding that they are not being considered by another publication. All articles become the property of the Florida Pharmacy Today and may not be published without written permission from both the author and the Florida Pharmacy Today. The Florida Pharmacy Association assumes no responsibility for the statements and opinions made by the authors to the Florida Pharmacy Today. The Journal of the Florida Pharmacy Association does not accept for publication articles or letters concerning religion, politics or any other subject the editors/ publishers deem unsuitable for the readership of this journal. In addition, The Journal does not accept advertising material from persons who are running for office in the association. The editors reserve the right to edit all materials submitted for publication. Letters and materials submitted for consideration for publication may be subject to review by the Editorial Review Board. FLORIDA PHARMACY TODAY, Annual subscription - United States and foreign, Individual $36; Institution $70/year; $5.00 single copies. Florida residents add 7% sales tax. Florida Pharmacy Association

610 N. Adams St. • Tallahassee, FL 32301 850/222-2400 • FAX 850/561-6758 Web Address: 8 |

Florida Pharmacy TodaY

HB 0101 Relating to University of South Florida – Representative McKeel SB 0838 Relating to University of South Florida/Doctor of Pharmacy – Senator Fasano Authorizes doctor of pharmacy degree program at the University of South Florida. HB 0135 Relating to Practice of Optometry – Representative Reagan SB 0330 Relating to Optometry/Oral and Topical Pharmaceutical Agents Practice of Optometry: Authorizes Board of Optometry to adopt rules for administration and prescription of oral ocular pharmaceutical agents; authorizes certified optometrists to administer and prescribe oral ocular pharmaceutical agents under certain circumstances; revises requirements for certified optometrist formulary of ocular pharmaceutical agents; revises qualifications of certain members of formulary committee; prohibits committee from reviewing requests or issuing advisory opinions or recommendations regarding oral ocular pharmaceutical agents; requires formulary to include certain oral ocular pharmaceutical agents; prohibits board from adding to, deleting from, or modifying formulary with respect to oral ocular pharmaceutical agents; revises definition to specify that certified optometrists are practitioners for purposes of Florida Comprehensive Drug Abuse Prevention and Control Act; Grants optometrists some prescribing authority for certain controlled substances. SB 0188 Relating to Advanced Registered Nurse Practitioners -- Bennett Advanced Registered Nurse Practitioners; Redefines the term “practitioner” for purposes of the Florida Comprehensive Drug Abuse Prevention and Control Act to include advanced registered nurse practitioners. Allows ARNP’s to prescribe controlled substances.

SB 0222 Relating to Childhood Vaccinations – Senator Ring Childhood Vaccinations; Requires a pediatrician or attending physician to discuss the risks, benefits, and alternatives of each vaccination before a child is vaccinated. Provides requirements for the administration of certain vaccines required for school entry. Requires licensed health care providers to provide certain vaccine information statements to parents, legal guardians, and legal representatives before administering certain vaccines to children, etc. HB 0225 Relating to Controlled Substances - Representative Legg Controlled Substances: Requires AHCA to contract with multistate electronic prescribing network to provide certain agencies with access to certain controlled substance information; requires AHCA to adopt rules and seek grants and donations; revises requirements for registration of pain-management clinics; requires DOH to refuse to register pain-management clinics under certain circumstances; specifies additional grounds for disciplinary action against certain licensed practitioners; requires community pharmacy permit applicants to demonstrate ability to participate in and transmit dispensing information through multistate electronic prescribing network; requires community pharmacy permittees to transmit dispensing information through such network for prescriptions of certain controlled substances; specifies additional ground for disciplinary action against community pharmacy permittees. The original bill as filed would have prohibited registered dispensing practitioners from dispensing more than a 72 hour supply of controlled substances with a few exceptions. However, that was amended from the bill. HB 275 Insurance Coverage for Prescription Drugs – Representative Grimsley SB 0516 Relating to Prescription Drugs Insurance Coverage – Senator Fasano Insurance Coverage for Prescrip-

tion Drugs: Prohibits limiting, reducing, or denying prescription drug coverage under health insurance policies or health maintenance contracts for individuals under specified circumstances; preserves insurer or HMO authority to make specified uniform changes; requires insurers and HMOs to notify insureds of such changes; specifies nonapplication to Medicaid managed care plans. HB 0373 Relating to Pain-Management Clinics – Representative Abruzzo Pain-Management Clinics: Prohibits person from owning or operating pain-management clinic unless he or she is physician with clear and active license to practice in Florida; provides that pain-management clinic may not be owned by, employ, or contract with certain physicians or certain persons; prohibits person from prescribing or dispensing any medication on premises of pain-management clinic unless he or she is licensed physician; provides exception for licensed pharmacist. HB 0517 Relating to Reproductive Health Services and Family Planning - Representative Gibson SB 0652 Relating to Reproductive Health Services/Rape Survivors – Senator Rich Reproductive Health Services and Family Planning: Creates “Prevention First Act”; provides duties of licensed health care practitioners and facilities relating to treatment of rape

survivors; requires AHCA to provide for enforcement and impose penalties; requires licensed pharmacies to dispense certain forms of contraception without delay; specifies conditions under which pharmacy may refuse to provide contraceptive. HB 0573 Relating to Physician Assistants Representative -- Kreegel Physician Assistants: Deletes requirements that physician assistants file evidence of certain clinical experience before prescribing or dispensing medication; authorizes electronic submission of physician assistant license applications and other required documentation. HB 0591 Relating to Health Insurance -Representative Roberson SB 1132 Relating to Antiretroviral Drugs Senator Sobel Health Insurance: Requires all antiretroviral agents to be included on health plan formularies; prohibits access limiting-procedures used to restrict antiretroviral agents prescribed to treat person with HIV; includes reference to such requirements on policies issued by out-of-state groups SB 0616 Relating to Prescription Drug Monitoring Program – Senator Ring Prescription Drug Monitoring Program; Requires that the

A Pharmacist And A Lawyer The Alternative To A Traditional Career In Pharmacy Car e e r n .

an occupation undertaken for a significant period of a person’s life, usually with opportunities for progress.

Brian A. Kahan, R.Ph., J.D. Licensed Florida Pharmacist and Attorney

• Professional Pay & Benefits • Special Clients, Flexible Assignments • A Variety Of Bonus Programs • Professional Development Opportunities/Cross Training



Pharmacist Attorney

• Guaranteed Hours


Board of Pharmacy Licensure Disciplinary Proceedings Defense of Chapter 499, Pedigree Laws Violations Mergers and Acquisitions Commercial, Civil and Criminal Proceedings



STATEWIDE REPRESENTATION 561-999-5999 1800 N.W. Corporate Blvd., Suite 200 Boca Raton, FL 33431 The hiring of a lawyer is an important decision that should not be based solely upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience.

04480 Hensley/RX Relief Florida Pharmacy Today—1/4 pg ad (3.5”x4.75”)

A P RIL 2 0 1 0



confidential and exempt information in the program database which is disclosed to the Attorney General or a law enforcement agency by the Department of Health be disclosed pursuant to a search warrant based upon probable cause. SB 0646 Relating to Pain-Management Clinics – Senator Aronberg Pain-Management Clinics; Prohibits a person from owning or operating a pain-management clinic unless he or she is a physician licensed in this state. Requires a physician’s license to be clear and active to own or operate a pain-management clinic. Provides that a pain-management clinic may not be owned by or employ a physician who has been disciplined by the Board of Medicine or the Board of Osteopathic Medicine for dependency on drugs or alcohol, etc. HB 0671 Relating to Pain-Management Clinics – Representative Skidmore SB 0804 Relating to Pain-Management Clinics Senator Gelber Pain-Management Clinics: Requires that privately owned pain-management clinics be registered with DOH by specified date; prohibits physician from practicing in pain-management clinic that is not registered; requires DOH to refuse to issue or revoke registration of certain pain-management clinics that are owned by person convicted of felony; requires DOH to annually inspect registered clinics; provides for automatic expiration of registration; requires payment of costs


24/7 Support

Pharmstaff pieces it all together: The Right Job. • Flexible Schedules • Top Compensation • Great Benefits • Local or Travel Assignments

The Right Candidate. • Fully Credentialed • Maximize Patient/ Customer Care • Improved Employee Satisfaction

800.223.9230 | Per Diem | Temporary | Permanent

Work with the Best © 2009 Medical Staffing Network, Inc. | PS-9005D



Florida Pharmacy TodaY

for registration and inspection or accreditation; requires rules setting forth standards of practice in privately owned painmanagement clinics; provides criteria for physicians that practice pain-management; provides that certain pain-management clinics are exempt from registration requirements under certain conditions; provides requirements for registering pain-management clinic; requires DOH to submit fingerprints of applicant for registration or renewal to FDLE and FBI for criminal records check; provides that applicants are not required to submit fingerprints under certain conditions. SB 0752 Relating to Health Care Fraud – Senator Gaetz Health Care Fraud; Prohibits the AHCA from issuing an initial license to a home health agency for the purpose of opening a new home health agency under certain conditions until a specified date. Authorizes the agency to revoke a home health agency license if the applicant or any controlling interest has been sanctioned certain for acts. Revises requirements for Medicaid prepaid, fixed-sum, and managed care contracts, etc. HB 0873 Relating to Controlled Substances – Representative Roberson SB 1260 Relating to Controlled Substances – Senator Fasano Controlled Substances: Revises list of controlled substances in Schedules I, II, III, IV, and V; provides that salts, isomers, or salts of isomers are included within certain substances listed in Schedule III. SB 1050 Relating to Ephedrine or Related Compounds/Sale - Senator Baker Ephedrine or Related Compounds/Sale; Prohibits obtaining or delivering to an individual in a retail sale any nonprescription compound, mixture, or preparation containing ephedrine or related compounds in excess of specified amounts. Requires a purchaser of a nonprescription compound, mixture, or preparation containing any detectable quantity of ephedrine or related compounds to meet specified requirements, etc. HB 1071 Relating to Sale of Ephedrine or Related Compounds - Representative Hays Sale of Ephedrine or Related Compounds: Prohibits obtaining or delivering in retail sale any nonprescription compound, mixture, or preparation containing ephedrine or related compounds in excess of specified amounts; revises provisions relating to retail display of products containing ephedrine or related compounds and retail employee training; provides requirements for purchasers of such products; requires use of electronic recordkeeping system approved by FDLE for such transactions to monitor and record specified information; provides for exemptions from electronic recordkeeping requirement; requires information submitted to system to be retained for specified period; revises language concerning local ordinances or regulations; provides exemptions

for certain entities; provides for disclosure of information in system under certain provisions; provides immunity from civil liability for release of certain information in compliance with electronic recordkeeping requirements; requires FDLE to contract with third party to implement system. HB 1117 Relating to Medicaid Fraud – Representative Randolph SB 1958 Relating to Medicaid Fraud – Senator Justice Medicaid Fraud: Requires DOH, OIR, DFS, and AHCA to deny, revoke, suspend, or refuse to issue or renew permits, certificates of authority, or licenses of specified entities that have been convicted of, or entered plea of guilty or nolo contendere to, regardless of adjudication, felony involving Medicaid fraud. HB 1149 Relating to Audits of Pharmacy Records Representative Gonzalez SB 2194 Relating to Audits of Pharmacy Records – Senator Peaden, Jr. Audits of Pharmacy Records: Revises requirements for audit of Medicaid-related pharmacy records; authorizes thirdparty payor and third-party administrator audits of pharmacies; provides that claims containing certain clerical or recordkeeping errors are not subject to financial recoupment; specifies that certain audit criteria apply to third-party claims submitted after specified date; prohibits certain accounting practices used for calculating recoupment of claims; prohibits audit criteria from requiring recoupment of claims except under certain circumstances; provides procedures for audit of third-party payor and third-party administrator audits. HB 1499 Relating to Controlled Substances – Representative Llorente Controlled Substances: Revises requirements for practitioner training on controlled substances; provides additional acts that constitute grounds for disciplinary actions against health professional licensees; requires registration of painmanagement clinics with DOH; provides application requirements; requires fingerprinting and criminal records checks of certain persons affiliated with pain-management clinics; revises requirements for prescribing and dispensing controlled substances at pain-management clinics; revises requirements for inspection of pain-management clinics; provides for suspension or revocation of pain-management clinic registrations; authorizes DOH to impose fines against painmanagement clinics; prohibits physicians from practicing in unregistered pain-management clinics; prohibits ownership or control of pain-management clinics by specified persons; provides penalties for certain violations; requires practitioners prescribing certain controlled substances in pain-management clinics to use counterfeit resistant prescription blanks; prohibits obtaining or seeking to obtain, with intent to obtain without medical necessity, controlled substance or prescription for controlled substance by misrepresentation, fraud, forgery, deception, subterfuge, or concealment of ma-

terial fact. HB 1561 Relating to Federal Health Care Legislation -- Representative Eisnaugle Federal Health Care Legislation: Urges Florida Attorney General to file suit challenging constitutionality of any individual health care mandate passed into law by Federal Government. SB 1722 Relating to Prescription Drug Monitoring Program – Senator Fasano Prescription Drug Monitoring Program; Requires that the comprehensive electronic database system containing information concerning prescriptions of controlled substances comply with the minimum requirements for authentication and certification of the National All Schedules Prescription Electronic Reporting Act. Authorizes the State Surgeon General to enter into agreements with other states to exchange prescription drug monitoring information after specified conditions are met, etc. SB 2272 Relating to Pain Management – Senator Fasano Pain Management; Requires the DOH and applicable boards within the DOH to approve a mandatory continuing education course for any practitioner who prescribes, administers, or dispenses controlled substances that are listed in Schedule II, Schedule III, or Schedule IV of ch. 893, F.S. Provides that pain-management clinics are business establishments subject to licensure by the DOH. Provides for requirements for the registration of pain-management clinics, etc. SB 2722 Relating to Controlled Substances – Senator Gardiner Controlled Substances [SPSC]; Requires the DOH to deny registration to any clinic that is not fully owned by a physician or group of physicians. Provides that the practice of medicine or osteopathic medicine in an unregistered painmanagement clinic is grounds for denial of licensure or disciplinary action. Prohibits registered dispensing practitioners form dispensing more than a specified amount of certain controlled substances, etc. n

A P RIL 2 0 1 0



Earth Month 2010: It’s Easy Being Green! Earth Day


April 22, 2010 is Earth Day, and more than a billion individuals across 190 countries will come together to work toward a healthier and more sustainable planet. CDC is proud to be a part of this effort. We recognize that healthier, safer people depend on a healthy environment. We are part of an ecosystem that we must protect in order to sustain our own ability to thrive and live healthy lives. CDC sees the health of our people and the health of our environment as interconnected. We integrate sustainable practices into our daily operations in order to: ■■ Reduce greenhouse gas emissions by reducing energy use ■■ Conserve natural resources through purchasing, operations and waste management ■■ Promote health and wellness ■■ Lead, communicate, and engage the community in sustainable practices


In 2008, CDC established the Agency-wide Go Green, Get Healthy initiative to reduce, reuse, and recycle resources; promote health; and encourage positive work environments. CDC employees work together in volunteer workgroups led by the CDC Office of Sustainability. All year round, but especially during Earth Month and on Earth Day, the workgroups cover the following sectors: ■■ Electronics Management ■■ Facilities and Greenspace & Water and Energy Conservation ■■ Food



Florida Pharmacy TodaY

■■ ■■ ■■ ■■

Source: Centers for Disease Control and Prevention

Green Communications Green Meetings Green Purchasing Recycling Transportation and Telework Worksite Wellness

National Environmental Education Week The 2010 National Environmental Education Week, led by a CDC partner, will address the issues of water and energy conservation through the theme “Be Water and Energy Wise.” This week is sponsored every year in mid-April by the National Environmental Education Foundation in anticipation and celebration of Earth Day. Its purpose is to promote understanding and protection of the natural world through learning and service. Find out more about how to Be Water and Energy Wise.

What You Can Do CDC wants to encourage you and your family, workplace, or community group to participate in or start up some activities in honor or Earth Month, Earth Day, or National Environmental Education Week. ■■ Consider transportation choices like biking, walking, carpooling, or using public transit. ■■ Consider electronic documents when possible; if you need to print do so responsibly (double sided, recycle paper when done).



Make environmentally conscious food choices. • Consider sustainable and local foods. • Hold a green potluck – bring healthy foods, use reusable plates, utensils, and napkins. Create your own green spaces – plant a tree or vegetable garden at home, school, or work!

Three R’s of Going Green: Reduce, Reuse, Recycle To go green and live green, remember the Three R’s: (1) reduce greenhouse gases in the environment, (2) reuse products, and (3) recycle items that can no longer be used. Going green leads to a healthier environment and a healthier environment leads to a healthier you! Improve the environment and your health using Three R’s of Going Green: ■■ Reduce or prevent waste to reduce greenhouse gases by using less and throwing away less. ■■ Reuse products by giving them to other people who want or need them instead of throwing them away. ■■ Recycle items made of materials such as glass, metal, plastic, or paper.

What It Means to “Go Green” and “Live Green” Reducing or preventing waste, reusing products, and recycling items are important ways to go green and live green. Going green and living green means changing our lifestyles to protect the environment in ways that also protect our health. The topics of going green, global climate change, and healthy community design are all linked. Going green reduces greenhouse gases released into the environment from burning fossil fuels and decomposing waste. Scientists think greenhouse gases in the atmosphere are a primary contributor to global climate change, which can harm people’s health. For example, climate change can produce severe weather, floods, and heat waves that injure people or make them sick. Also, greenhouse gases in the air we breathe can interact with sunlight and create ozone. Ozone along with soot particles from burning fossil fuels, which is called “particulate matter,” are two of the main things in polluted air that can cause people to have breathing problems such as asthma. So when we go green to reduce greenhouse gases released into

GAPCOM_PHARMJour-12-09:Layout 1 12/17/09 10:27 AM Page 1


PCOM School of Pharmacy – Georgia Campus SHAPING PHARMACY EDUCATION FOR TOMORROW’S LEADERS PCOM is proud to offer a new Doctor of Pharmacy (PharmD) degree. Providing future pharmacists with the tools for community and hospital practices, long-term and managed care consulting, pharmacy management, research and academia. PCOM School of Pharmacy – Georgia Campus is now accepting applications. For more information, e-mail us at or apply now at Philadelphia College of Osteopathic Medicine’s Doctor of Pharmacy program has applied for accreditation status by the Accreditation Council for Pharmacy Education, 20 North Clark Street, Suite 2500, Chicago, IL 60602-5109, 312/644-3575; FAX 312/664-4652, Web site, For an explanation of ACPE accreditation process, consult the Office of the Dean, or ACPE.










A P RIL 2 0 1 0



the environment, we are helping avoid health effects related to climate change and air pollution. Another way to go green and live green is by designing and building healthy communities. In healthy communities, community members live and work in buildings and landscapes that are: ■■ Bike paths and walking trails; ■■ Community centers or other social gathering places; ■■ Parks and ample green space; ■■ Accessible public transit; ■■ Affordable housing that allows people of all incomes to live close to their jobs and retire in the community if they choose to; and ■■ Higher-density land use so homes, workplaces, schools, and recreation are closer together and people can walk or bike more easily to their destination. Ways a community with those design elements could improve health include: ■■ Decreasing vehicle use, which reduces air pollution and greenhouse gases in the environment, improves air quality, reduces the risk of injury from vehicle crashes, and avoids contributing to climate change; ■■ Promoting physical activity, which gives benefits such as helping with weight control and reducing risk for developing heart disease; and ■■ Increasing social connectedness and improving mental health by giving people more time, opportunities, and



Florida Pharmacy TodaY

pleasant surroundings for activities such as socializing, playing, and engaging in physical activity.

CDC Helps You Make Green Choices for Healthy Living The Centers for Disease Control and Prevention (CDC), whose mission is to promote public health, gives you information you can use to go green and make choices that are good for both the environment and your health. The CDC Healthy Places Web site explains the concept of designing and building active communities that make it easier for people to live healthy lives. The CDC Climate Change and Public Health Web site tells about the potential health effects from climate change and about CDC’s efforts to anticipate, prevent, and respond to them. CDC’s experts have long been in the forefront of education and advocacy concerning going green, designing and building healthy communities, and protecting the public from the health effects of climate change. In the November 2008 special issue of the American Journal of Preventive Medicine (AJPM), guest editors from CDC and Australian National University’s National Centre for Epidemiology and Population Health and their colleagues issue a call to action on climate change and public health. Articles from the special issue, including five available free to nonsubscribers, are available online.

CDC’s Recommendations CDC makes the following recommendations for going green and living green: 1. Reduce or prevent waste to reduce greenhouse gases by using less and throwing away less. Decreasing consumption of products and reducing or preventing waste lowers the amount of greenhouse gases emitted to the environment during resource extraction, manufacturing, trash burning, and decomposition of trash in landfills. You can also help the environment and your health when you reduce energy consumption. For instance, the Energy Star program of the US Environmental Protection Agency and the US Department of Energy estimates that if the five most frequently used light fixtures or the bulbs in them in every American home were replaced with Energy Star bulbs, energy costs nationwide would be lowered by a total of almost $8 billion annually, and we would prevent amounts of greenhouse gas releases to the environment equivalent to the emissions from nearly 10 million cars. 2. Reuse products to prevent waste and improve our communities. Reusing products means that useful products discarded by people who no longer want or need them are given to people who do. Nearly every community can reuse products. For example, community members can: ■■ Use durable coffee mugs instead of disposable cups, ■■ Use cloth napkins or towels instead of paper ones, ■■ Refill water bottles, ■■ Donate old magazines or clothing, ■■ Reuse boxes, and ■■ Participate in a paint collection and reuse program. Reusing a product means it continues to be of value, it’s useful, and it’s productive.  More important, reusing an item instead of replacing it with something new means we don’t use more resources to create new items.

3. Recycle items to get maximum value from them, use resources wisely, and avoid damage to the environment and our health. Recycling is beneficial not only environmentally but also financially and socially. Materials such as glass, metal, plastics, and paper are collected, separated, sent to processing facilities, and reprocessed into new materials. Recycling items that would otherwise be discarded means that those items will not have to be disposed of as trash. According to the US Environmental Protection Agency, 82 million tons of material was diverted away from landfills and incinerators in 2006, up from 34 million tons in 1990. Recycling also helps us use energy and other resources more wisely and avoid damage to the environment and our health. With recycling, we reprocess previously manufactured items instead of using resources and materials to manufacture new ones. You can find out more about recycling and take the recycling pledge on the National Recycling Coalition’s Web site for America Recycles Day.

Use the Three R’s of Going Green To protect your health and the environment by going green and living green, remember and use the Three R’s: (1) reduce or prevent waste, (2) reuse products, and (3) recycle. You may think the changes are small, but small changes can add up to big differences. Going green leads to a healthier environment, and a healthier environment leads to a healthier you!

A P RIL 2 0 1 0






Have you been searching for just the right gift or thought of placing your name in perpetuity? If so, then consider purchasing an engraved brick for you or someone else. The main sidewalk at the Florida Pharmacy Association needs replacing. The Florida Pharmacy Foundation has undertaken the project to repair and beautify the sidewalk with engraved personal bricks purchased by pharmacists or friends of pharmacy. Engraved 4x8 bricks can be purchased for $250.00 each with the donor’s name engraved (3 lines available) or you could also purchase an engraved brick for someone you feel should be honored or remembered. The monies earned from this project will be used to fulfill the goals and future of the Foundation. There are a limited number of bricks available – so, it is first come first served.


The Walkway of Recognition

❑ YES, I want to order _______ concrete brick/s at $250.00 each. (Please copy form for additional inscriptions). PLEASE PRINT INSCRIPTION

The concrete bricks are 4x8 and can be engraved with up to 14 characters per line, three lines available, spaces and punctuation count as one character. Please find enclosed my check for $_________ for _________ bricks. PLEASE PRINT: Please charge my

❑ Master Card


Contributions to the Florida Pharmacy Foundation are tax deductible as a charitable contribution for federal income tax purposes. Consult your CPA for complete details. Fed Emp. I.D. #59-2190074

❑ Visa EXP. DATE





Send to Florida Pharmacy Foundation, 610 N. Adams St., Tallahassee, FL 32301, or fax to (850) 561-6758.



A P RIL 2 0 1 0





June 30 - July 4, 2010 Marco Island Marriott Resort, Golf Club & Spa ♦ Marco Island, Florida Poster Session: Friday, July 1, 2010, 4:30-6:00PM

The FPA Poster Presentations are open to PHARMACY STUDENTS ONLY. Complete and submit this COVERSHEET for each abstract submission. Submissions must be received no later than Monday, May 3, 2010. Abstracts will NOT be accepted after this date. Mail or E-mail this application along with the abstract submission to: Tian Merren Owens, MS, PharmD, Director of Continuing Education Florida Pharmacy Association 610 N. Adams Street Tallahassee, FL 32301


Contact Information: Presenter's Name (MUST BE A STUDENT):________________________________________________________________

□ Entry Level Pharm.D. □ Post B.S. Pharm.D. Address: ________________________________________________________________________________________

City, State, Zip: ___________________________________________________________________________________ Telephone No: _____________________E-Mail Address: _________________________________________________ Abstract Title: ____________________________________________________________________________________ Poster Type:

□Clinical Research □Basic Science Research □Translational Research (Basic Science and Clinical Research)

Primary Author: __________________________________________________________________________________ (Students must be listed first to be considered for the Award. Presenter will be notified by mail of acceptance). Co-Author(s): _________________________________________________________ Student



Posters will be eligible for 1st, 2nd, and 3rd place prizes to be presented at Convention. (Only one prize is given for each winning poster)

Free Registration:

Three entry level students from each Florida College of Pharmacy will be eligible for a complimentary Florida Pharmacy Association Convention Student registration. (Student Registration does not include CE or hotel accommodations) I am interested in being considered for this registration:





ABSTRACT FORMAT The abstract form submitted should be the equivalent of one page. The abstract should include: Title (Include authors’ names and name of College of Pharmacy), Purpose, Methods, Results, and Conclusions. Abstracts will not be accepted if it is not in this format. Do not include figures or graphs.

Please direct all questions and concerns to:

Tian Merren Owens ♦ (850) 222-2400 ext. 120 ♦ DEADLINE DATE: MONDAY, MAY 3, 2010 18


Florida Pharmacy TodaY

Florida Pharmacy Association


n o i t a r o b olla

120th Annual Meeting and Convention Marco Island Marriott Resort, Golf Club & Spa Marco Island, FL

June 30 - July 4, 2010

Mark Your Calendar!

Collaboration is a process where two or more people or organizations work together in an intersection of common goals. Pharmacists collaborate with healthcare professionals in order to provide optimal patient care. Pharmacists are an integral part of the healthcare delivery system and make a powerful impact on improving patient’s quality of life. FPA would like to educate, equip and enhance pharmacists’ therapeutic knowledge with practical tools as they collaborate with other healthcare professionals and make a difference in patient care. FPA’s mission is to “serve, represent and assist pharmacists and pharmacy technicians to advance the profession and practice of pharmacy.” This year’s convention will offer a variety of important topics that will be applicable to your pharmacy practice setting. We are offering consultant and general continuing education hours, in addition to a pre-convention conference on Current Trends in Medication Therapy Management. Come and Collaborate at FPA’s 120th Annual Meeting and Convention! A P RIL 2 0 1 0



FPA 120th Annual Meeting and Convention Schedule June 30-July 4, 2010


Wednesday, June 30, 2010 6 hrs GCE - Separate registration fee required 8:00am 8:45am

Registration/Check-in Welcome and Introductory Remarks

9:00am-4:00pm Current Trends of Medication Therapy Management 9:00am-10:30am Education: 1.5 hrs GCE The Role of Medication Therapy Management (MTM) in Pharmacy’s Future Lorelei Lucas, PharmD, Clinical Instructor, University of Mississippi School of Pharmacy and Lauren Compton, PharmD, Community Pharmacy Resident, University of Mississippi School of Pharmacy Upon completion of this activity, pharmacists will be able to: DeďŹ ne MTM services, with speciďŹ c focus on pharmacy MTM; Discuss the importance of pharmacist-provided MTM and the rationale to support pharmacy practitioners embracing these opportunities; Describe the educational model for pharmacists and how this model prepares graduates to provide MTM services. UAN: 0165-0000-10-037-L04-P 10:30am-12:00pm Education: 1.5 hrs GCE Current Environment: Pharmacy MTM Models Tommy Spells, PharmD, Pharmacy Owner of Biggs Drugstore, Clinical Coordinator of Community Pharmacy Development, University of Mississippi School of Pharmacy Upon completion of this activity, pharmacists will be able to: Identify MTM services provided under the Medicare Part D model; Discuss innovative services provided through state Medicaid programs; Review successful employer-based prevention and treatment programs; Describe a successful regional community-based pharmacy MTM program; Implement Pillcounter model objectives. UAN: 0165-0000-10-038-L04-P 12:00pm-12:30pm CODE KEY: 20

Lunch (Attendees on their own)

GCE = General Continuing Education |

Florida Pharmacy TodaY

12:30pm-2:00pm Education: 1.5 hrs GCE The Horizon: Pharmacy MTM Models Leigh Ann Ross, PharmD, BCPS, Associate Dean for Clinical Aairs, Chair of the Department of Pharmacy Practice, University of Mississippi School of Pharmacy Upon completion of this activity, pharmacists will be able to: Discuss pharmacy MTM and health care reform; Discuss state initiatives to advance pharmacy practice and how this may impact pharmacy MTM opportunities. UAN: 0165-0000-10-039-L04-P 2:00pm-3:30pm Education: 1.5 hrs GCE Building a Successful MTM Practice Through Collaboration Don Thibodeau, PharmD, Owner of the PillHelp Company, LLC Upon completion of this activity, pharmacists will be able to: Construct a plan to Fit MTMS into his/her life by Building a part-time or full-time practice; Overcoming the biggest hurdle: Finding Time; Optimizing time while providing care; Describe the Keys to eective MTMS collaboration; Identify when the Right Time is to begin practicing MTMS; Appraise the Collaborators that make it work: Physicians / Consumers / Pharmacists UAN: 0165-0000-10-040-L04-P 4:00pm-5:00pm 5:00pm-6:00pm 6:00pm-7:00pm 6:00pm-8:00pm 7:30pm-9:00pm

HOD Board of Directors Meeting Florida Pharmacy PACCE Meeting Budget & Finance Committee Meeting Florida Pharmacy Foundation Annual Meeting OďŹƒcer’s Dinner

Thursday, July 1, 2010 6 hrs of GCE/TECH or 3 hrs RC 6:00am Registration Desk Open 7:00am-8:30am Education: 1.5 hrs GCE/TECH/RC Diabetes Collaboration: Meals, Meds and Monitoring Part 1 – Medication and Monitoring Basics for the Busy Pharmacist

RC = Recertification Consultant

TECH = Technician

STC = Student Continuing Education

Kris Swenson, RN, CDE, Founder and Director of Program Development for Diabetes Management & Training Centers, Inc., Phoenix, Arizona and DeAnn Mullins, RPh, CDE, Owner, WeCare Mullins Pharmacy, WeCare Diabetes Education Program Upon completion of this activity, pharmacists will be able to: Interpret the patients own blood glucose and food records to identify effective medication strategies; Use blood glucose monitoring data to support and improve medication adherence/ compliance; Formulate effective medication strategies (insulin/ oral/incretins/amylin) to improve blood glucose control. UAN: 0165-0000-10-014-L01-P Upon completion technicians will be able to: Define diabetes; Identify advantages of collaborating with other healthcare professionals; Recognize normal blood glucose levels; List medications used to improve blood glucose. UAN: 0165-0000-10-014-L01-T 8:35am-10:05am Education: 1.5 hrs GCE/TECH/RC Part 2 – Nutrition and Monitoring Basics for the Busy Pharmacist Kris Swenson, RN, CDE, Founder and Director of Program Development for Diabetes Management & Training Centers, Inc., Phoenix, Arizona and DeAnn Mullins, RPh, CDE, Owner, WeCare Mullins Pharmacy, WeCare Diabetes Education Program Upon completion of this activity, pharmacists will be able to: Interpret the patients own blood glucose and food records to identify opportunities to improve diabetes control; Advise patients on appropriate portion and carbohydrate management (the diabetic diet is dead); Determine effective nutrition strategies to maintain or improve blood glucose control. UAN: 0165-0000-10-015-L01-P Upon completion technicians will be able to: Identify ways to improve diabetes control; Recognize the importance of nutrition in diabetes patients; List effective nutrition strategies to maintain blood glucose control. UAN: 0165-0000-10-015-L01-T 10:05am-10:15am Break 10:15am-11:15am Education: 1 hr GCE/TECH Legislative and Regulatory Update Michael Jackson, BPharm, CPh, Florida Pharmacy Association Executive Vice President and CEO Upon completion of this activity, pharmacists and technicians will be able to: Recite recent changes in pharmacy laws CODE KEY:

GCE = General Continuing Education

which affect the practice of pharmacy in Florida; Describe issues of state and national interest to the profession pharmacy; Identify recent statutory changes that affect the role of pharmacy technicians. UAN: 0165-0000-10-036-L03-P UAN: 0165-0000-10-036-L03-T 11:20am-12:20pm Education: 1 hr GCE/TECH Medication Therapy Management: A Call to Collaborate Mike McQuone, RPh, MS, CPh, Executive Vice President / CEO, Florida Society of Health-system Pharmacists Upon completion of this activity, pharmacists and technicians will be able to: Define medication therapy management (MTM); Describe the application of MTM to various pharmacy practice areas (institutional, community, etc.); List three (3) or more barriers to the implementation of MTM; Describe the role of professional pharmacy associations (national, state, regional/local) in promoting collaboration regarding MTM; List three (or more) personal goals to include MTM in your pharmacy practice. UAN: 0165-0000-10-016-L04-P UAN: 0165-0000-10-016-L04-T 11:20am-1:20pm CE Provider Workshop for Florida Department of Health Providers (Non CE Credit) Linda Brunson, CE Broker; Kelli Ferrell, FL Department of Health, Board of Pharmacy; Carl “Fritz” Hayes, Florida Board of Pharmacy Member 12:20pm-1:20pm Lunch (Attendees on their own) 12:20pm-1:20pm Annual Business Meeting 1:25pm-2:25pm Education: 1 hr GCE/TECH/STC Keynote Address: Answering the Medication Use Crisis through Health Care Reform Tom Menighan, Executive Vice President and CEO of APhA Upon completion of this activity, pharmacists and technicians will be able to: Describe the challenges and opportunities within the current economic and political environment for the profession of pharmacy to implement a new model of care and assume an expanded patient care role; Identify the necessary steps by each stakeholder group to obtain recognition for pharmacists’ expanded patient care roles on the health care team; Describe initiatives undertaken by APhA and the profession to

RC = Recertification Consultant

TECH = Technician

STC = Student Continuing Education A P RIL 2 0 1 0



advance the pharmacist’s patient care role within a reformed health care system; Discuss the latest activities related to health care reform and the role of the pharmacist. UAN: 0165-0000-10-017-L04-P UAN: 0165-0000-10-017-L04-T 2:30pm-6:00pm 2:30pm-6:30pm 4:30pm-6:00pm 7:00pm-8:00pm

Exhibit Hall Grand Opening Journal Board Meeting Adopt-A-Student and Mentor Social Foundation Reception Social

Analyze the usage and effectiveness of over-the-counter medications; Classify different groups of over-the-counter medications based on drug treatment classes. UAN: 0165-0000-10-019-L04-P Upon completion of this activity, technicians will be able to: Identify the use of over-the-counter medications; List the classes of various OTC products; Identify proper storage and handling techniques of OTC products. UAN: 0165-0000-10-019-L04-P 8:35am-10:05am Education: 1.5 hrs GCE/TECH/RC Management of Atrial Fibrillation from the Electrophysiologist’s Perspective Saumil R. Oza, MD, F.A.C.C., Diagnostic Cardiology Associates, Jacksonville, FL Upon completion of this activity, pharmacists will be able to: Recognize the burden of atrial fibrillation (AF); Review the current understanding of the pathophysiology of AF; List risk factors for AF; Recommend pharmacological and non-pharmacological therapies to prevent AF; Identify when rhythm control or rate control is the preferred AF treatment strategy; Review surgical procedures currently being employed to maintain sinus rhythm. UAN: 0165-0000-10-020-L01-P Upon completion technicians will be able to: Recognize the burden of atrial fibrillation; List risk factors for AF; List medications used to treat AF. UAN: 0165-0000-10-020-L01-T

Friday, July 2, 2010 8 hrs of GCE/TECH or 4.5 hrs RC 6:00am Registration Desk Open 6:30am-7:00am Golf Tournament Practice 6:30am-7:30am Christian Pharmacist Fellowship International Breakfast 7:30am PACCE Golf Tournament 7:00am-8:30am Education: 1.5 hrs GCE/TECH/RC Pharmacological Management of Atrial Fibrillation and Overview of Novel Anticoagulants Benjamin Epstein Pharm.D., BCPS, Assistant Professor of Pharmacy and Medicine, UF College of Pharmacy and Medicine Upon completion of this activity, pharmacists will be able to: Recognize the burden of atrial fibrillation (AF); Recommend pharmacological and non-pharmacological therapies to prevent AF; Recommend appropriate antiarrhythmic treatment to achieve and maintain sinus rhythm (SR); Describe the common side effects, toxicities, and monitoring for antiarrhythmic drugs. UAN: 0165-0000-10-018-L01-P Upon completion technicians will be able to: Define atrial fibrillation; Identify treatments used to prevent AF; List common side effects of medications used to treat AF. UAN: 0165-0000-10-018-L01-T 8:00am-10:00am Education: 2 hrs GCE/TECH/STC NASPA/NMA Game Show Tian Merren Owens, PharmD, MS, Director of Continuing Education, Florida Pharmacy Association Upon completion of this activity, pharmacists will be able to: Identify and explain aspects of the effective and safe practice of pharmacy self care treatments through a process of answering a selected group of questions similar to a national board exam;


GCE = General Continuing Education |

Florida Pharmacy TodaY

10:00am-12:00pm Delegate Registration 10:05am-10:15am Break 10:15am-11:15am Education: 1 hr GCE/TECH/STC Health Care Reform: Wins, Losses, and Opportunities for Pharmacy Kristina Lunner, Vice President, Government Affairs, American Pharmacists Association Upon completion of this activity, pharmacists and technicians will be able to: Describe the pharmacy’s efforts in the Congressional debate on health care reform; Identify the areas of the health care reform package that affect pharmacy practice; Describe the next steps in the regulatory process required to implement health care reform proposals. UAN: 0165-0000-10-021-L04-P UAN: 0165-0000-10-021-L04-T

RC = Recertification Consultant

10:15am-11:45am Education: 1.5 hrs GCE/TECH/RC Principles of Geriatric Pharmacotherapy Jeff Delafuente, M.S., FCCP, FASCP, Associate Dean for Professional Education and Professor, Virginia Commonwealth University School of Pharmacy Upon completion of this activity, pharmacists will be able to: TECH = Technician

STC = Student Continuing Education

Describe the effects of aging on pharmacokinetic and pharmacodynamic parameters; Identify common medication-related problems of geriatric patients; Discuss the principles of why some medications are deemed potentially inappropriate for older patients; Describe how medications can prevent and contribute to functional decline in the elderly; Identify other health care providers who can collaborate with you to improve therapeutic outcomes in older patients. UAN: 0165-0000-10-022-L01-P Upon completion technicians will be able to: Identify medications that cause problems in the elderly population; Explain why some medications are not appropriate for the elderly; List other health care providers who can assist with the profession of pharmacy to improve patient care in the elderly. UAN: 0165-0000-10-022-L01-P 11:15am-3:00pm Student Patient Counseling Competition 11:20am-12:20pm Education: 1 hr GCE/TECH/STC Pharmacist Survival: 3rd Party Audits Deb Thompson, Cardinal Health Managed Care Upon completion of this activity, pharmacists will be able to: Operate the pharmacy in a manner which is compliant with Florida rules, statutes and laws; Create a standard to meet 3rd party requirements; Inspect prescriptions closely to avoid violations from 3rd party payors. UAN: 0165-0000-10-023-L04-P Upon completion technicians will be able to: Recognize the role and purpose of 3rd party audits; Identify areas in the practice of pharmacy that are not in compliance with 3rd party payors; List the consequences pharmacies may encounter when 3rd party auditors do not pay claims. UAN: 0165-0000-10-023-L04-T 12:20pm-1:00pm Lunch (Attendees on their own) 1:00pm-2:00pm Education: 1 hr GCE/TECH/STC How to stay in the PHARMACY and out of the COURTROOM Carl Gainor Ph.D., J.D., Professor at Universities of Arizona, Pittsburg, West Virginia, and LECOM Bradenton Schools of Pharmacy Upon completion of this activity, pharmacists will be able to: Identify the present trends in malpractice litigation and the reasons for increased emphasis on drug-related litigation; Recognize the difficulties and disadvantages in defending lawsuits involving drug related claims; Assess actual case examples involving drug-related claims to demonstrate practices and procedures that have resulted in drug-induced adverse events and litigation; Formulate suggestions for minimizing drug-related CODE KEY:

GCE = General Continuing Education

malpractice exposure. UAN: 0165-0000-10-024-L04-P Upon completion technicians will be able to: Recognize the reasons for increased emphasis on drug related litigations; List the disadvantages in defending lawsuits involving drug related claims; Create suggestions for minimizing drug-related malpractice exposure. UAN: 0165-0000-10-024-L04-T 1:00pm-3:00pm Education: 2 hrs GCE/TECH Reducing Medication Errors through Implementing a Continuous Quality Improvement Program Michael Jackson, BPharm, CPh, Florida Pharmacy Association Executive Vice President and CEO Upon completion of this activity, pharmacists should be able to: Define elements of a Continuous Quality Improvement (CQI) Program; Restructure a pharmacy practice to address quality related events; Analyze some common causes of quality related events; Implement an action plan to address quality of care in pharmacies with a goal towards error reduction and prevention; Recite quality improvement regulations for Florida pharmacies. UAN: 0165-0000-10-025-L05-P Upon completion of this activity, technicians should be able to: Define CQI; List most common medication errors; Employ techniques to reduce medication errors by using CQI. UAN: 0165-0000-10-025-L05-T 1:00pm-3:00pm Local Unit Leaders Meeting 2:00pm-3:00pm Education: 1 hr GCE/TECH What Pharmacy Technicians Can and Cannot Do Under Florida Law Gail Brown, CPhT, BS, Pharmacy Technician Program Manager/Extern Coordinator, High-Tech Institute, Inc. Upon completion of this activity, pharmacists and technicians will be able to: List key legal cases that help support technician legislation; Discuss what SB1360 says and means to technicians, for the pharmacy department and for Florida’s patients; Define: pharmacy technician, certification and registration; Distinguish between technician duties and pharmacy intern duties – understanding the chain of command; Using scenarios, create a workflow to assess when a technician may perform a task or when the task must be elevated to an intern or pharmacist. UAN: 0165-0000-10-026-L04-P UAN: 0165-0000-10-026-L04-T 2:00pm-3:00pm Education: 1 hr STC (Non CE Credit) The Clinical Pearls of Testing Todd Rosen PharmD, Publix Supermarkets, Inc.

RC = Recertification Consultant

TECH = Technician

STC = Student Continuing Education A P RIL 2 0 1 0



the role of cholinergic and glutaminergic neurotransmission in cognition; Review the mechanisms of action, dosing and common adverse effects of three cholinerterase inhibitors, donepezil, rivastigmine, and galantamine and the NMDA antagonist memantine; Differentiate the various kinds of dementias as they pertain to presentation, treatment options and outcomes; Discuss the positive and negative impact that other medications may have in the elderly population with dementia. UAN: 0165-0000-10-028-L01-P Upon completion technicians will be able to: Define Alzheimer’s disease; List signs and symptoms associated with Alzheimer’s disease; Identify treatments for a patient with Alzheimer’s disease. UAN: 0165-0000-10-028-L01-T

Upon completion of this activity, students should be able to: Discuss various therapeutic disease states; Identify treatment regimens for different disease categories; Review clinical questions that may improve testing techniques. 3:00pm-5:00pm FPA House of Delegates Education: 1 hr GCE/TECH/STC Issue Presentation (3:10pm-4:10pm) 4:30pm-6:00pm 4:30pm-7:00pm 5:30pm 7:00pm-8:30pm 8:00pm-9:30pm

Student Poster Presentations Exhibit Hall Opens Golf Winners Announced in Exhibit Hall PACCE Wine and Cheese Reception University Alumni Receptions

Saturday, July 3, 2010 7 hrs of GCE/TECH or 6 hrs RC 6:00am

Registration Desk Open

7:00am-8:30am Education: 1.5 hrs GCE/TECH/RC The Collaboration of Medications in Treating Parkinson’s Disease Day Scott, Pharm.D., BCPS, CPh, Director of Experiential Programs; Institutional Practice, Assistant Professor of Pharmacy Practice; Lloyd L. Gregory School of Pharmacy Upon completion of this activity, pharmacists will be able to: Explain the clinical presentation of Parkinson’s disease; Discuss current pharmacotherapeutic options for the treatment of Parkinson’s disease; Recommend treatment for a patient with Parkinson’s disease, given initial clinical presentation; Identify potential complications arising from Parkinson’s disease and associated therapies, along with methods to reduce such complications. UAN: 0165-0000-10-027-L01-P Upon completion technicians will be able to: Define Parkinson’s disease; List some signs and symptoms of Parkinson’s disease; Identify treatments for a patient with Parkinson’s disease. UAN: 0165-0000-10-027-L01-T

9:00am-11:00am Education: 2 hrs TECH/STC (Non CE Credit) Pharmacy Career Forum Jim Powers-Facilitator. Presenters: Theresa Tolle-Independent Pharnacy; Bob Hoye-Compounding Pharmacy; Stephen Grabowski-Long Term Care Pharmacy; Don Thibodeau-MTM Private Practice; Norm Tomaka-Consultant Practice Upon completion of this activity, participants should be able to: Recognize various practices of pharmacy and opportunities available to pharmacists; Describe the practice setting that best suit the individual skills and abilities; Identify personal strengths and weaknesses to consider when contemplating career choices. 10:05am-10:15am Break

8:35am-10:05am Education: 1.5 hrs GCE/TECH/RC Update and Review of the Pharmacological Treatment of Alzheimer’s Disease and Other Dementias Jose Rey, PharmD, ,BCPP, Associate Professor, Nova Southeastern University – College of Pharmacy Upon completion of this activity, pharmacists will be able to: Review the pathophysiology of Alzheimer’s Disease and CODE KEY: 24

GCE = General Continuing Education |

Florida Pharmacy TodaY

RC = Recertification Consultant

10:20am-11:50am Education: 1.5 hrs GCE/TECH/RC Whose job is it anyway? Taking care of the HIV-infected patient through collaborative practice: Part I Lisa Inge Pharm.D. BCPS, AAHIVE, Assistant Professor of Pharmacotherapy & Translational Research, University of Florida, College of Pharmacy Upon completion of this activity, pharmacists will be able to: Define the term “collaborative practice”; Describe factors that enhance or hinder the development of collaborative practice; Identify potential opportunities for the collaboration between the physician and pharmacist in treatment of HIVinfected individuals. UAN: 0165-0000-10-029-L02-P Upon completion technicians will be able to: Define HIV; Explain the benefit of collaborative practice in taking care of the HIV infected patient; List factors that affect the development of collaborative practice; List medications used to treat patients infected with HIV. UAN: 0165-0000-10-029-L02-P TECH = Technician

STC = Student Continuing Education

11:15am-1:00pm Student Banquet/Awards/Scholarships 12:00N-1:00pm

Lunch (Attendees on their own)

12:00N-1:00pm Education: 1 hr GCE/TECH Florida Board of Pharmacy Update Rebecca Poston, RPh, Executive Director of Florida Board of Pharmacy Upon completion of this activity, pharmacists should be able to: Describe the purpose of the Board of Pharmacy and its relationship to state government; Recognize recent changes in the Board of Pharmacy administrative rules affecting the practice of pharmacy; Identify proposed changes to the Board of Pharmacy administrative rules that are under consideration. UAN: 0165-0000-10-030-L03-P Upon completion of this activity, technicians should be able to: Describe the purpose of the Florida Board of Pharmacy; Recognize recent changes in the Board of Pharmacy that affect the profession of pharmacy; Recognize changes in the Board that affect pharmacy technicians. UAN: 0165-0000-10-030-L03-T 1:00pm-2: 30pm Education: 1.5 hrs GCE/TECH/RC Whose job is it anyway? Taking care of the HIV-infected patient through collaborative practice: Part II Levonne Mitchell-Samon, MD Upon completion of this activity, pharmacists will be able to: Illustrate the importance of collaboration between the pharmacist and medical providers in antiretroviral treatment; Discuss the benefits of the hospital pharmacist as a member of the healthcare team in the treatment of HIV-infected patients; Analyze patient scenarios to identify how the potential for collaboration could have been incorporated to improve patient care. UAN: 0165-0000-10-031-L02-P Upon completion technicians will be able to: Recognize the importance of collaboration between the pharmacist and other healthcare providers when treating HIV patients; Explain the benefits and advantages of having a pharmacist as part of the healthcare team in the treatment of HIV-infected patients; List some disadvantages of not having a pharmacist as part of the healthcare team when treating patients infected with HIV. UAN: 0165-0000-10-031-L02-T 1:00pm-2:30pm Education: 1.5 hrs GCE/TECH/STC LEAD, FOLLOW, OR GET OUT OF THE WAY Wayne Cheatum, MS, RPh, CPh, Public Health Preparedness Consultant Pharmacist Upon completion of this activity, pharmacists and technicians will be able to: Define the roles and responsibilities of a CODE KEY:

GCE = General Continuing Education

leader; Discuss methods and means of obtaining success as a leader; Recognize the important characteristics of a leader. UAN: 0165-0000-10-032-L04-P UAN: 0165-0000-10-032-L04-T 1:00pm-2:30pm Delegate Registration 2:30pm-4:30pm House of Delegates Reconvenes 5:00pm-6:30pm Past Presidents Reception (Invitation Only) 6:00pm-10:00pm Awards Ceremony Reception - Ticketed event THEME: AN EVENING IN MARGARITAVILLE Dress Code: Resort Wear Casual/Evening Beach Attire

Sunday, July 4, 2010 4.5 hrs of GCE/TECH/RC 6:00am Registration Desk Open 6:30am-8:00am President’s Breakfast and Installation of Officers 8:00am-9:30am Education: 1.5 hrs GCE/TECH/RC The Pharmacist Role in Managing Acute and Chronic Pain Elias Chahine, PharmD, BCPS, Assistant Professor of Pharmacy Practice, Palm Beach Atlantic University, Clinical Pharmacist, JFK Medical Center Upon completion of this activity, pharmacists will be able to: Define pain; Explain the pathophysiology of nociceptive and neuropathic pain; List examples of nociceptive, neuropathic and functional pain; Distinguish between acute pain and chronic pain; Explain the patient-centered approach to assess pain; Discuss nonpharmacologic treatment for pain; Compare and contrast commonly used NSAIDs and opiods in the treatment of pain; Discuss the role of adjuvant analgesics in the treatment of pain; Recommend an appropriate pain management regimens for patients with acute pain and chronic pain including cancer pain; Given patient-specific information, formulate a monitoring plan for a patient receiving opioids for the treatment of pain. UAN: 0165-0000-10-033-L01-P Upon completion technicians will be able to: Define pain; List the different types of pain; Describe the difference between acute pain and chronic pain; Define NSAIDs and list commonly used NSAIDS in the treatment of pain. UAN: 0165-0000-10-033-L01-T

RC = Recertification Consultant

TECH = Technician

STC = Student Continuing Education A P RIL 2 0 1 0



9:35am-11:05am Education: 1.5 hrs GCE/TECH/RC Hospice and Palliative Care Suzanne Kelley, RPh, Covenant Hospice Upon completion of this activity, pharmacists will be able to: Compare the deďŹ nitions of hospice care and palliative care; Describe the history of hospice and its “modernâ€? movement; Identify the members of the interdisciplinary team (IDT) and their importance in the patients’ care; Describe the six constituents of EOL care; Recognize the role of the pharmacist and the importance of symptom management in the care of the “terminal patientâ€?. UAN: 0165-0000-10-034-L04-P Upon completion technicians should be able to: DeďŹ ne hospice care and palliative care; Describe the hospice history; Identify the hospice (IDT) members and their role in caring for the patient; List the value of pharmacy technicians in the six constituents of EOL care. UAN: 0165-0000-10-034-L04-T 11:05am-11:20am Break 11:20am-12:50pm Education: 1.5 hrs GCE/TECH/RC Management of Febrile Neutropenia Elias Chahine, PharmD, BCPS, Assistant Professor of Pharmacy Practice, Palm Beach Atlantic University, Clinical Pharmacist, JFK Medical Center Upon completion of this activity, pharmacists will be able to: Identify risk factors for infections in patients with cancer; Calculate an absolute neutrophil count; DeďŹ ne neutropenia and febrile neutropenia; Explain the general approach for the management of patients with febrile neutropenia; Distinguish between low risk neutropenia and high risk neutropenia; Identify the most common microorganisms associated with febrile neutropenia; Compare and contrast commonly used antibiotics and antifungals in febrile neutropenia; Discuss the role of colony stimulating factors in neutropenia; Recommend an appropriate management regimen for patients with febrile neutropenia; Discuss the role of prophylactic antimicrobials in patients expected to experience prolonged neutropenia; Given patient-speciďŹ c information, formulate a monitoring plan for a patient receiving an antimicrobial regimen for the treatment or prevention of febrile neutropenia. UAN: 0165-0000-10-035-L01-P Upon completion technicians will be able to: Recognize risk factors for infections in patients with cancer; DeďŹ ne neutropenia and febrile neutropenia; List the most common organisms associated with febrile neutopenia; Recognize most commonly used antibiotics and antifungals used in the treatment of febrile neutropenia. UAN: 0165-0000-10-035-L01-T Consultant Track



Florida Pharmacy TodaY

Mark Your Calendar 2011 Annual Convention and Meeting June 22-26, 2011 5IF'BJSNPOU5VSOCFSSZ Isle Resort & Club 8FTU$PVOUSZ$MVC%S "WFOUVSB '- (305) 932-6200 3PPNSBUF

The Florida Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of Continuing Pharmacy Education. Up to 31.5 contact hours are available upon successful completion of the program through attendance and submission of completed attendance forms. Statements of continuing pharmacy education will be mailed six weeks after the meeting. The Florida Pharmacy is also a Florida Department of Health approved provider of continuing education for pharmacists. This is an ACPE application based activity.



Marco Island Marriott Resort, Golf Club & Spa 400 South Collier Boulevard Marco Island, FL 34145 (239) 394-2511 or (800) 438-4373 Room Rate: $149

ome kick o your shoes and explore paradise found at this one-of-a-kind Florida resort, now celebrating the completion of a $187 million renovation and redesign that has infused every moment here with the spirit of Balinese beauty, hospitality and well-being - and added even more wondrous experiences to this already acclaimed destination. Nestled on three miles of pristine Southwest Florida beaches, the Marco Island Marriott Beach Resort Golf Club and Spa is the perfect destination for a family vacation, a romantic retreat, a memorable meeting or an unforgettable wedding. With several renowned restaurants, championship golf, a world-class spa and a wide range of activities and amenities, Marco Island Marriott Beach Resort Golf Club and Spa now oers even more - including upscale shops for men and women, a freeform fantasy pool with views of the Florida Gulf, new dining options and completely redesigned and redecorated guest rooms. A P RIL 2 0 1 0



General Information General Information Room Rates

$149 (rate cut off date is Friday, June 11, 2010) The special Florida Pharmacy Association Group room rate is $149 single/double occupancy plus tax per night. Please be sure to ask for the Florida Pharmacy Association group rate. The check-in time is after 4:00pm and the checkout time is before 11:00am. Room reservations can be made by calling (800) 438-4373 or calling (239) 394-2511. Valet parking is $18 per car per day. Guest self parking is $12 per car per day.

Keynote Speaker

Tom E. Menighan, is Executive Vice President and Chief Executive Officer of APhA, a position he assumed July 2009. Mr. Menighan received his Bachelor of Science in Pharmacy from West Virginia University School of Pharmacy and a Masters in Business from Averett College. He represents and is the chief spokesman for the American Pharmacists Association. Throughout his career, Menighan has served volunteer roles within the profession of pharmacy, including president of APhA from 2001 to 2002 and a member of the APhA Board of Trustees between 1995 and 2003. Also, he was a senior staff member of APhA from 1987 to 1992.

General Education Track

Thursday - Sunday The general education track will offer courses designed to educate pharmacists on a wide variety of important topics pertaining to the profession of pharmacy practice. Specific courses being offered are Reducing Medication Errors, Third Party audits, and a Board of Pharmacy Update as well as the always-popular offerings of Florida Regulatory and Legislative Update.



Florida Pharmacy TodaY

Consultant Education Track

Thursday- Sunday The consultant education track will provide pharmacists with the most current information available on various disease states and focus on collaboration with other healthcare professionals. Some specific therapeutic topics being offered include Diabetes Management, HIV/AIDS, Cardiovascular Disease, Neurological Disorders, and Oncology. There are 18 hours available for consultant pharmacists.

Student and Technician Track

Thursday – Sunday Students and Technicians will benefit from interacting with practicing pharmacists and attending student and technician focused continuing education programs. The technician track offers several hours of continuing education on a variety of topics, including a course on What Technicians Can and Cannot Do in Pharmacy. The student track consists of 10 hours of fun and exciting continuing education. Some specific courses being offered include Pharmacy Law, The Career Forum, and the NASPA/NMA Game Show.

Pre-Convention Education

Wednesday Only Our traditional Wednesday program will discuss current trends in Medication Therapy Management (MTM). This outstanding MTM Program will offer 6 hours of live continuing education credit. Register for these programs and walk away with valuable information for your pharmacy practice. A separate registration fee is required for the pre-convention program.

Special Events

Exhibits: Participate in our grand opening reception in the exhibit hall! Poster Presentations: Browse submissions from students. Contact Tian Merren Owens in the FPA office for more information if you would like to submit a poster presentation. Awards Ceremony Reception entitled An

Evening in Margaritaville: Honor outstanding practitioners during the awards presentation. The dress code is resort wear casual or evening beach attire. President’s Breakfast: Attend the Sunday morning installation of new officers. Receptions: Enjoy catching up with your colleagues as the Universities entertain their alumni and friends, and as the FPA Foundation thank their supporters at a reception. House of Delegates: Be a delegate or observer and see how important member participation is to the direction of the Association. Student Events: Students will benefit from interacting with practicing pharmacists, attending student focused continuing education programs and learning first hand about the FPA and how involvement can improve their chosen profession. Call the FPA office and offer to mentor or sponsor a student. PharmPACCE Wine and Cheese Reception: Purchase a ticket to this reception to support your Political Action Committee. Golf Tournament: Join us Friday morning for the PACCE Golf Tournament. Please register early to save your space.

Waiver of Liability

Each individual attending FPA’s Annual Meeting assumes all risks associated with his/her attendance and participation in all on-and off-site activities that occur during this time. By registering for this meeting, you agree to indemnify and hold harmless, FPA and its governing bodies, officers and employees from all loss, damage or liability arising out of or related to your attendance and participation at FPA’s Annual Meeting.

Cancellation Policy

If cancellation is made in writing 30 days prior to the program a refund will be made less a $10 service charge. If cancellation is made 29-10 days prior to the program, a refund will be made, less a $50 service charge. Cancellation requested in writing after that date will result in credit for another FPA CE program or service valid for one year.

A P RIL 2 0 1 0



Florida Pharmacy Association 610 North Adams Street Tallahassee, FL 32301

120th Annual Meeting and Convention Marco Island Marriott Resort, Golf Club & Spa Marco Island, FL

June 30 - July 4, 2010

C 30


Florida Pharmacy TodaY

n o i t a r o b olla

PRSRT STD US Postage PAID Tallahassee, FL Permit #236

Drug Enforcement Administration Releases Interim Final Rule To Permit Electronic Prescriptions for Controlled Substances Effective June 1, 2010 April 7, 2010 Summary On March 31, 2010, the Drug Enforcement Administration (DEA) published its interim final rule (IFR) with comment period that will allow electronic prescribing of controlled substances. Specifically, the IRF permits appropriately credentialed prescribers to voluntarily transmit Schedules II-V controlled substance prescriptions electronically to pharmacies beginning June 1, 2010. This rule finalizes a proposed rule released on June 27, 2008. The Federal Register notice (75 16236) is available online. While this rule represents an interim final rule with an effective date, DEA has substantially changed many of the provisions from the proposed rule and therefore seeks feedback. Comments on the IFR are due June 1, 2010 and can be submitted online at to Docket No. DEA-218. Additionally, the IFR is classified as a major rule and is subject to Congressional review to be completed by June 1, 2010. APhA is preparing additional information for members regarding this rule and plans to draft recommendations for providing comments to DEA. APhA will make future resources available on and through future issues of the APhA Legislative and Regulatory Update e-Newsletter. For additional information, DEA has posted a series of questions and answers regarding the IFR which is available on the DEA Web site. Background The IFR rule updates regulations implemented pursuant to the Controlled Substances Act (CSA) that previously required Schedule II controlled substances to be dispensed by a pharmacist pursuant to a written prescription order, except in emergency situations. The CSA also previously permitted Schedules III-V controlled substances only to be dispensed pursuant to a written, oral, or facsimile prescription order. The IFR provides an allowance, not a mandate, for prescribers to voluntarily use electronic means to transmit controlled substance prescriptions. Pharmacists who dispense controlled substance prescriptions transmitted electronically must ensure that all existing DEA requirements for controlled substance prescriptions are met. The IFR contains revisions to the proposed rule, including different methods for identifying prescribers and for transmitting controlled substance prescriptions. DEA states that these A P RIL 2 0 1 0



APhA Summary of DEA e-Prescribing of Controlled Substances Interim Final Rule

APha Summary April 7, 2010of DEA e-Prescribing of Controlled Substances Interim Final Rule | April 7, 2010

changes are the result of nearly two years of work between DEA and the Department of Health and Human Services, the Office of the National Coordinator for HIT, the Centers for Medicare and Medicaid Services, and the Agency for Health Research and Quality. DEA aims to ensure that the system for transmitting controlled substance prescriptions electronically ensures consistency with other federal initiatives to implement a nationwide system of electronic health records while maintaining the security measures necessary to prevent diversion. In addition, DEA seeks to allow more flexibility for prescribers and pharmacies to use updated e-prescribing (e-Rx) systems, technologies, and standards without the need for additional rulemaking or approval. DEA received approximately 230 comments in response to the 2008 proposed rule, including from APhA. APhA appreciates that DEA considered many of the concerns of pharmacy to implement improvements that recognize pharmacy workflow issues. Read APhA’s summary of the proposed rule and comment letter. Goals and Overview of IFR DEA requirements in developing the IFR are: • The approach must meet DEA’s statutory mandates. Only DEA registrants may be granted the authority to sign controlled substance electronic prescriptions. • The method used to authenticate a practitioner to the electronic prescribing system must ensure to the greatest extent possible that the practitioner cannot repudiate the prescription. Authentication methods that can be compromised without practitioner awareness are not acceptable. • Electronic prescriptions must include all information required for paper controlled substance prescriptions. • The prescription records must be reliable enough to be used in legal actions without having to substantially expand the number of witnesses that need to be called to verify records. • The pharmacy system must allow annotation of the records as required for paper prescriptions and must indicate who made each annotation. • The security systems used by any of the service providers must, to the greatest extent possible, prevent the possibility of insider creation or alteration of controlled substance prescriptions. Computer-generated prescriptions that are printed out or faxed are not electronic prescriptions for DEA purposes. However, DEA will continue to allow computer-generated or printed faxes to serve as prescriptions for controlled substances pursuant to existing DEA regulations. Prescriber Identity Proofing, Access Control to E-Prescribing Systems, Two-Factor Authentication, and Approving Electronic Controlled Substance Prescriptions To maintain security and assure proper identification of prescribers, DEA adopts an approach to identity proofing and logical access controls that prevents one single person from granting access to an e-Rx application or a pharmacy application. To transmit controlled substance prescriptions electronically, prescribers must: a) receive authentication credentials or digital signatures by private organizations that are federally recognized credential service providers, credential authority, or internal institutional credentialing authorities; and b) receive permission to access the e-Rx system using logical access controls involving two individuals, one of whom is a DEA



Florida Pharmacy TodaY


APhA Summary of DEA e-Prescribing of Controlled Substances Interim Final Rule APha Summary of DEA e-Prescribing of Controlled Substances Interim Final Rule April 7, 2010

| April 7, 2010

registrant. Once the prescriber has received appropriate credentials or digital signature and has been granted access to the e-Rx system, then the prescriber must sign the prescription using a two-factor authentication method. DEA believes that this approach will provide flexibility and security when transmitting prescription information. DEA seeks further comment on these changes. •

Identity proofing: Unlike the proposed rule that relied upon DEA registered hospitals, State licensing boards, and State or local law enforcement agencies to conduct in-person identity proofing, the IFR relies upon entities that are federally approved to provide identity proofing according to National Institute of Standards and Technology (NIST) SP 800-63-1, Level 3, which allows for in-person or remote identity proofing. Institutions may use its own internal identity proofing through its in-house credentialing process. The credentialing body will not check the prescriber’s DEA registration status, but will rather conduct the appropriate checks necessary to verify the individual’s identity. The issuance of a credential is not linked to each DEA registration that the prescriber holds. Prescribers who use e-Rx systems that have different credentialing bodies may be required to receive credentials from multiple organizations. Identity proofing will be updated based upon the discretion of the credentialing body.

Logical Access Controls: Once the prescriber has received the appropriate identity proofing credentials, he or she must then be given access to the e-Rx system by two designated individuals, one of who must be a DEA registrant. The designated individuals will vary by practice or location and approved prescribers may be designated by name or by role, such as nurse, nurse practitioner, etc. One individual provides data entry and then the registrant grants system access. The individuals who are responsible for logical access controls will verify the prescriber’s authentication credentials and DEA registration before granting signing access.

Two-Factor Authentication: Once a prescriber has been granted access to the system, then he or she may use two-factor authentication to approve the prescription. Access to the electronic prescribing system for the purposes of signing prescriptions must require at least a two-factor authentication process. Prescribers must select from two of the following: o Something you have (hard token separate from computer that meet Federal Information Processing Standard (FIPS) 140-2 Security Level 1) o Something you know (user ID and password or PIN), or o Something you are (biometrics). The final rule does not require the use of a hard token as described in the proposed rule. Rather, the prescriber must choose between two of the three available authentication factors. DEA does not support the use of passwords alone because the level of security is not sufficient to prevent unauthorized access. Only the DEA registrant who has been given access to the system may sign the prescription. Agents may not be given access to or use two-factor authentication to sign prescriptions. However, agents may enter prescription information for later approval and authentication by prescribers.

A P RIL 32 0 1 0



APhA Summary of DEA e-Prescribing of Controlled Substances Interim Final Rule

APha Summary April 7, 2010of DEA e-Prescribing of Controlled Substances Interim Final Rule | April 7, 2010 •

Approving prescriptions: When a prescriber is prepared to sign a prescription, a review screen containing a list of patient prescriptions for approval will appear. Prescribers must use the two-factor authentication to sign prescriptions issued for each patient. The review screen will also contain a notification that completion of two-factor authentication approves the prescription. The notice will not require a separate keystroke to acknowledge as in the proposed rule. The proposed rule required a timeout after two minutes of the prescriber not using the system; however, this requirement has been eliminated from the IFR.

Use of digital signature as an alternative to authentication: In the proposed rule, DEA allowed for the use of public key infrastructure (PKI)/digital signatures in federal facilities. In the IFR, DEA will allow for the use of digital signatures for non-federal agencies because many commenters suggested that this approach would be beneficial for prescribers who transmit directly to pharmacies without using intermediaries, such in long-term care settings. Prescribers must receive digital signatures from a certification authority cross certified with the Federal PKI Policy Authority at a basic assurance level or above.

Transmitting Controlled Substance Prescriptions Unlike the proposed rule, the IFR does not require that the prescription be transmitted immediately upon two-factor authentication. Rather, the prescriber may complete the two-factor authentication and the prescription may be transmitted to the pharmacy later. The prescription for transmission must contain all of the required data according to Schedule (date of issuance of the prescription; patient name; registrant full name, address, DEA registration number; drug name, dosage form, quantity prescribed, and directions for use; and any other information specific to certain controlled substances prescriptions mandated by law or DEA regulations). Changes permitted after an e-prescription transmission include: • Pharmacies may change the prescription to accommodate generic substitution. • The prescription is not required to contain the patient’s address when approved by the prescriber for two-factor authentication but must be added prior to transmitting to the pharmacy. • Other non-DEA required information may also be added to the prescription file after approval but before transmission, such as the pharmacy’s URL. DEA suggests that this method of transmission allows for information to be shared and reviewed by nurses at long-term care facilities and in other circumstances. • Intermediaries may make formatting changes after transmission. Once the two-factor authentication is complete, the prescriber must digitally archive the prescription. Then, either the pharmacy or the last intermediary to receive the prescription must digitally sign the prescription, which must be archived by the pharmacy. E-Rx System Requirements DEA will not personally audit or approve prescriber or pharmacy systems used to transmit or receive controlled substance prescriptions. Rather, systems must be audited by a third-party for compliance with DEA requirements. Audits must be preformed every two years or whenever the application is altered in a way that could affect the functionalities within the electronic



Florida Pharmacy TodaY


APhA Summary of DEA e-Prescribing of Controlled Substances Interim Final Rule APha Summary of DEA e-Prescribing of Controlled Substances Interim Final Rule April 7, 2010

| April 7, 2010

prescription or pharmacy application related to controlled substance prescription requirements, whichever occurs first. Under the proposed rule, the third-party audits were required to meet SysTrust or WebTrust, or SAS 70 audit for security and processing integrity. The IFR expands the third-party auditors to include certified information system auditors (CISA) that perform compliance audits as a regular ongoing business activity. DEA clarifies that prescribers or pharmacies would not be responsible for audits unless it uses a proprietary application. DEA states that in most cases, prescribers and pharmacies contract with application service providers that will be responsible for these audits. The e-Rx systems must be able to accommodate DEA requirements for paper prescriptions, including multiple DEA registration numbers when applicable to mid-level practitioners; institutional suffixes used by institutional prescribers using a hospital DEA registration; “do not fill� instructions when issuing multiple Schedule II prescriptions; and notes for indicating when methadone and other controlled substances for addiction are prescribed outside of a treatment program. Audit Requirements Both the application service provider and the pharmacy/prescriber must maintain internal audit records of circumstances when e-prescriptions were annotated, changed, modified, or deleted or where an interruption of the functionality of the system occurs in violation of the rules. The audit log must include the time, date, action, and person taking the action. System security issues must be reported to DEA within one business day. DEA allows for flexibility for registrants and application service providers to record auditable events. DEA specifically states that generic substitution of a medication is not considered to be a modification that meets the criteria for an auditable event. Refill Authorizations and Transferring Schedule III-V Prescriptions Electronically A prescriber may authorize refills for Schedule III-IV prescriptions electronically so long as the refills do not exceed 5 times within 6 months. (Note: DEA does not limit the number of refills on Schedule V prescriptions.) Prescriptions may be electronically transferred between pharmacies so long as all of the other DEA requirements for a prescription are met. Partial filling of prescriptions The partial filling of a prescription for a Schedule II controlled substance is allowed if the full quantity of a written or emergency oral prescription cannot be supplied. The pharmacist must document the quantity supplied on the face of the written prescription, written record of the emergency oral prescription, or in the electronic prescription record. The remainder of the prescription may be filled within 72 hours of the first partial fill; if not, the pharmacist must notify the prescriber and a new prescription would be required for further quantities. Transmission Failures If an electronic transmission to a pharmacy fails, a prescriber may print a hard copy of a prescription and manually sign it. The prescription must include information that the

A P RIL 5 2010



APhA Summary of DEA e-Prescribing of Controlled Substances Interim Final Rule

APha Summary April 7, 2010of DEA e-Prescribing of Controlled Substances Interim Final Rule | April 7, 2010

prescription was originally transmitted electronically, date of transmission, and the name of the pharmacy. The pharmacy must verify that the prescription was not received and no prescriptions were filled prior to receipt of the hard copy prescription. Pharmacies that receive unsigned eprescriptions must treat the prescriptions in the same manner as unsigned paper prescriptions for controlled substances. Printing Copies of Prescriptions Permissible Unlike the proposed rule, the IFR allows printing of copies of electronic prescriptions that must be clearly marked as a copy. Printed copies of e-prescriptions cannot be printed in cases when transmission fails; rather, a hard copy must be used. Finally, as noted below, the printed copy is not suitable to meet DEA recordkeeping requirements for e-prescriptions. Recordkeeping Requirements All records of digitally archived e-prescriptions for controlled substances must be maintained electronically for two years consistent with other DEA recordkeeping requirements. The proposed rule had required that records be maintained for five years. Pharmacy records must be backed up daily. Unlike the proposed requirement that records be maintained offsite, the IFR does not specify where records must be stored but DEA does recommend storage at another location as a best practice. Records must be readily retrievable (available within 48 hours) in human, readable form for DEA inspection. Prescribers must generate monthly logs of controlled substances prescribed electronically. The proposed rule required that prescribers review and act upon the monthly logs but this requirement has been eliminated from the IFR.



Florida Pharmacy TodaY


FPA Officer and Director Nominations Although we have just finished the election for a president-elect and directors for the even numbered regions to be installed at the 2010 annual meeting, it is time to start thinking about nominees for the 2010 election since the nomination deadline is September 1 of this year (9/1/10). As the form below indicates, this year we will need candidates for president-elect, treasurer, and directors for the odd numbered regions. Please note that you may nominate yourself. CALL FOR FPA OFFICER AND DIRECTOR NOMINATIONS for 2011 Elections The FPA By-Laws specify that any subdivision or any member in good standing may nominate one person for the office of President-Elect and one person for the office of Treasurer. A President-Elect shall be elected every year and shall assume the duties of the President on the last day of the annual meeting of the year following election as President-Elect. The treasurer shall serve a two year term and may succeed to one consecutive term of office in that capacity. Nominees must be Florida registered pharmacists in good standing with the Florida Pharmacy Association and the Florida Board of Pharmacy. Nominees for president-elect should have a good understanding of how the Association functions and should be current on the issues impacting pharmacy. Nominees for treasurer should have good analytical skills and experience and ability in financial management and budget preparation. There are nine regional Board Directors who shall serve two year terms. Nominees must be a Florida registered pharmacist in good standing with the Florida Pharmacy Association and the Florida Board of Pharmacy. Additionally, Board Directors must be a member of at least one the FPA Unit Associations within their region. Board Directors terms are staggered such that even numbered regions shall be elected in even numbered years and odd numbered regions shall be elected in odd numbered years. All newly elected Board of Directors Regional Directors shall take office on the last day of the annual meeting, and shall continue in office until the last day of annual meeting of the second ensuing year.



(Nomination Deadline September 1, 2010)

q q q

President-Elect Treasurer Board Director Region 1 (Units: Escambia, Okaloosa-Walton, Leon, Alachua) Region 3 (Units: Pasco-Hernando, Pinellas) Region 5 (Units: Hillsborough, Polk) Region 7 (Units: Palm Beach, Gulfcoast) Region 9 (Units: Broward)


MAIL NOMINATIONS TO: Election Nominations, Florida Pharmacy Association, 610 N. Adams St., Tallahassee, FL 32301 (850) 222-2400 FAX (850) 561-6758 DEADLINE FOR NOMINATIONS IS SEPTEMBER 1, 2010

A P RIL 2 0 1 0



Buyer’s Guide florida PHARMACY TODAY

ADVERTISERS: This is a special section designed to give your company more exposure and to act as an easy reference for the pharmacist.

Support Our Advertisers! Use the “Buyer’s Guide” PHARMACY RESOURCES

PHarmaceutical WHOLESALER

PPSC Retail Pharmacy Purchasing Program (888) 778-9909

McKesson Drug Company Jim Springer (800) 804-4590 FAX: (863) 616-2953

PHARMACY CONSULTANTS HCC Pharmacy Business Solutions Dean Pedalino (800) 642-1652 Mobile: (727) 460-1855



Medical Staffing Network (800) 359-1234

Meadowbrook Workers Comp Insurance Endorsed by FPA (800) 825-9489

HealthCare Consultants Pharmacy Staffing Bob Miller (800) 642-1652

Rx Relief (800) RXRELIEF

LEGAL ASSISTANCE Kahan ◆ Shir, P.L. Brian A. Kahan, R.Ph., and Attorney at Law (561) 999-5999

FREQUENTLY CALLED NUMBERS AHCA MEDICAID PHARMACY SERVICES 2727 Mahan Drive Tallahassee, FL 32308 (850) 487-4441 pharmacy AMERICAN PHARMACISTS ASSOCIATION (APhA) Washington, D.C. (800) 237-2742 AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS Bethesda, MD (301) 657-3000 Drug Information Center Palm Beach Atlantic University (561) 803-2728 FLORIDA BOARD OF PHARMACY 4052 Bald Cypress Way Bin #C04 Tallahassee, FL 32399-3254 (850) 245-4292 FLORIDA POISON INFORMATION CENTER NETWORK 1-800-282-3171 pcc/fpicjax.htm National Community Pharmacists Association 100 Daingerfield Road Alexandria, VA 22314 703.683.8200 703.683.3619 fax Recovering Pharmacists Network of Florida (407) 257-6606 “Pharmacists Helping Pharmacists”

Advertising in Florida Pharmacy Today Display Advertising: please call (850) 264-5111 for a media kit and rate sheet. Buyers’ Guide: A signed insertion of at least 3X per year, 1/3 page or larger display ad, earns a placement in the Buyers’ Guide. A screened ad is furnished at additional cost to the advertiser. Professional Referral Ads: FPA Members: $50 per 50 words; Non‑members: $100 per 50 words; No discounts for advertising agencies. All Professional Referral ads must be paid in advance, at the time of ad receipt. 38


Florida Pharmacy TodaY

April 2010 Florida Pharmacy Journal  

April 2010 issue

April 2010 Florida Pharmacy Journal  

April 2010 issue